Simeprevir in hepatitis C: Added benefit for certain patients
The drug simeprevir (trade name: Olysio) has been available since May 2014 for the treatment of adult patients with chronic hepatitis C infection. In an early benefit assessment pursuant to the Act on the Reform of the Market ...
Sep 8, 2014
0
0